Merit Medical Systems (MMSI)
(Delayed Data from NSDQ)
$88.74 USD
+4.62 (5.49%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $88.71 -0.03 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MMSI 88.74 +4.62(5.49%)
Will MMSI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MMSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MMSI
Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up
Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
MMSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merit Medical (MMSI) Q2 Earnings and Revenues Beat Estimates
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
Other News for MMSI
Merit Medical Systems, Inc. (MMSI) Q2 2024 Earnings Call Transcript
Buy Rating Affirmed for Merit Medical Systems on Strong Q2 Performance and Upbeat Financial Outlook
Merit Medical price target raised by $3 at Piper Sandler, here's why
Assessing Merit Medical Systems: Insights From 6 Financial Analysts
Merit Medical Systems Inc (MMSI) Q2 2024 Earnings Call Transcript Highlights: Record Free Cash ...